Variant report
Variant | rs2982461 |
---|---|
Chromosome Location | chr1:169029531-169029532 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:169027600-169031000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr1:169028000-169030000 | Enhancers | Stomach Mucosa | stomach |
3 | chr1:169028000-169030400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr1:169028200-169030400 | Enhancers | Adipose Nuclei | Adipose |
5 | chr1:169028800-169029600 | Enhancers | Gastric | stomach |
6 | chr1:169028800-169030000 | Enhancers | Fetal Intestine Large | intestine |
7 | chr1:169028800-169030000 | Flanking Active TSS | A549 | lung |
8 | chr1:169028800-169030400 | Enhancers | Psoas Muscle | Psoas |
9 | chr1:169028800-169030400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
10 | chr1:169028800-169030800 | Enhancers | Fetal Intestine Small | intestine |
11 | chr1:169028800-169030800 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr1:169028800-169030800 | Enhancers | Small Intestine | intestine |
13 | chr1:169028800-169031000 | Flanking Active TSS | Hela-S3 | cervix |
14 | chr1:169029000-169029800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr1:169029000-169029800 | Enhancers | Duodenum Mucosa | Duodenum |
16 | chr1:169029000-169029800 | Enhancers | Placenta | Placenta |
17 | chr1:169029000-169030000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
18 | chr1:169029000-169030400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
19 | chr1:169029000-169030400 | Enhancers | NHEK | skin |
20 | chr1:169029200-169029800 | Enhancers | Lung | lung |
21 | chr1:169029200-169029800 | Active TSS | Rectal Mucosa Donor 29 | rectum |
22 | chr1:169029200-169029800 | Flanking Active TSS | HepG2 | liver |
23 | chr1:169029200-169030000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
24 | chr1:169029200-169030000 | Enhancers | Right Ventricle | heart |
25 | chr1:169029200-169030400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
26 | chr1:169029200-169030400 | Enhancers | Left Ventricle | heart |
27 | chr1:169029200-169030800 | Enhancers | Fetal Heart | heart |
28 | chr1:169029200-169030800 | Enhancers | Placenta Amnion | Placenta Amnion |
29 | chr1:169029200-169031000 | Enhancers | Primary monocytes fromperipheralblood | blood |
30 | chr1:169029200-169031400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
31 | chr1:169029400-169029600 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
32 | chr1:169029400-169029800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
33 | chr1:169029400-169030000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
34 | chr1:169029400-169030400 | Enhancers | Right Atrium | heart |
35 | chr1:169029400-169030800 | Enhancers | HUVEC | blood vessel |
36 | chr1:169029400-169030800 | Enhancers | K562 | blood |
37 | chr1:169029400-169031000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
38 | chr1:169029400-169031400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |